Literature DB >> 17082011

A novel mutation of the cytochrome-b5 reductase gene in an Indian patient: the molecular basis of type I methemoglobinemia.

Roberto H Nussenzveig1, H Bindu Lingam, Amos Gaikwad, Qiqing Zhu, Naijie Jing, Josef T Prchal.   

Abstract

We report here a novel mutation in the cytochrome b5 reductase gene resulting in type I methemoglobinemia. A single T->C transition in exon 8 at position 25985 was identified, changing codon 217 from Leu to Pro (L217P). The mutation is located in the NADH binding domain at the base of alpha-helix Nalpha3, a region of sequence highly conserved from yeast to man. A quantitative assessment of the thermodynamic cost of this mutation at 37 degrees C revealed a ten-fold drop in the free energy of stability. Alterations in hydrogen bonding and solvent accessibility surrounding residue 217 were predicted based on computer modeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082011

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Molecular basis of two novel mutations found in type I methemoglobinemia.

Authors:  Felipe R Lorenzo; John D Phillips; Roberto Nussenzveig; Bindu Lingam; Parvaiz A Koul; Stanley L Schrier; Josef T Prchal
Journal:  Blood Cells Mol Dis       Date:  2011-02-24       Impact factor: 3.039

2.  Methemoglobinemia in a young man.

Authors:  Yasmin S Hamirani; Wayne Franklin; Ronald G Grifka; Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2008

3.  Clinical, metabolic, and molecular genetic characterization of hereditary methemoglobinemia caused by cytochrome b5 reductase deficiency in 30 dogs.

Authors:  J A Jaffey; N S Reading; O Abdulmalik; R Kreisler; G Bullock; A Wiest; N A Villani; T Mhlanga-Mutangadura; G S Johnson; L A Cohn; N Isaza; J W Harvey; U Giger
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.